euro adhoc: Sartorius AG
Board of Directors (Appointments and
Changes)
Extension of appointment of the Executive Board Member
Biotechnology Division (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
It was resolved in the Sartorius AG´s Supervisory Board meeting dated December 18th, 2003 to extend the appointment of Dr. Eric Janssens, who is Executive Board Member Biotechnology Division since December 7th, 2001, until December 31st, 2006.
end of announcement euro adhoc 19.12.2003
Further inquiry note:
Thomas Hartwig
CFO
Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: CDAX, Prime All Share, Prime Standard, Technologie All Share
Börsen: Niedersächsische Börse zu Hannover / official dealing
Frankfurter Wertpapierbörse / official dealing
Berliner Wertpapierbörse / free trade
Bayerische Börse / free trade
Hamburger Wertpapierbörse / free trade
Bremer Wertpapierbörse (BWB) / free trade
Börse Düsseldorf / free trade
Baden-Württembergische Wertpapierbörse / free trade